IGFBP-3 Promoter Polymorphism -202A>C (rs2854774) Contributes to Prostate Cancer Risk: Evidence Based on 9,482 Subjects

Publisher： Karger

E-ISSN： 1423-0399|93|1|100-107

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.93, Iss.1, 2014-01, pp. : 100-107

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Association between the 8473T>C Polymorphism of PTGS2 and Prostate Cancer Risk: A Metaanalysis Including 24,716 Subjects

By  

Oncology Research and Treatment, Vol. 36, Iss. 4, 2013-03 ,pp. : 182-186

Karger

Access to resources Recommend Favorite

Lack of Evidence for the Association of E-Cadherin Gene Polymorphism with Increased Risk or Progression of Prostate Cancer

By  

Urologia Internationalis, Vol. 72, Iss. 3, 2004-04 ,pp. : 203-207

Karger

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor-γ Polymorphism, Body Mass and Prostate Cancer Risk: Evidence for Gene-Environment Interaction

By  

Oncology, Vol. 70, Iss. 3, 2006-07 ,pp. : 185-189

Karger

Access to resources Recommend Favorite

The Interleukin-6 –174G/C Polymorphism and Prostate Cancer Risk: A Systematic Review and Meta-Analysis

By  

Urologia Internationalis, Vol. 88, Iss. 4, 2012-04 ,pp. : 447-453

Karger

Access to resources Recommend Favorite

E-Cadherin Gene 3′-UTR C/T Polymorphism Is Associated with Prostate Cancer

By  

Urologia Internationalis, Vol. 75, Iss. 4, 2005-12 ,pp. : 350-353

Karger

Access to resources Recommend Favorite